Insider Stock Trading History of Akkaraju Srinivas


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Akkaraju Srinivas since year 2005. The trader's CIK number is 1253170. At the time of this reporting, Akkaraju Srinivas is the Director of Versartis, Inc. . (stock ticker symbol VSAR). See this page for all insider trading activities at Versartis, Inc. .

Note that in the past AKKARAJU SRINIVAS also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Akkaraju Srinivas since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-03-24 VSAR Versartis, Inc. Buy 571,429 12.25 7,000,005
2016-10-03 VSAR Versartis, Inc. Buy 571,429 12.25 7,000,005
2016-05-13 ICPT Intercept Pharmaceuticals Inc Option Ex 1,500 21.50 32,250
2015-10-28 ICPT Intercept Pharmaceuticals Inc Option Ex 1,250 21.50 26,875
2015-05-19 ICPT Intercept Pharmaceuticals Inc Option Ex 1,000 21.50 21,500
2015-05-12 LIFE Atyr Pharma Inc Buy 320,000 14.00 4,480,000
2014-11-11 ICPT Intercept Pharmaceuticals Inc Option Ex 2,500 21.50 53,750
2014-11-12 ICPT Intercept Pharmaceuticals Inc Buy 2,000 165.04 330,072
2014-10-16 ICPT Intercept Pharmaceuticals Inc Option Ex 324 .00 0
2014-07-16 ICPT Intercept Pharmaceuticals Inc Option Ex 325 .00 0
2014-04-16 ICPT Intercept Pharmaceuticals Inc Option Ex 324 .00 0
2014-01-16 ICPT Intercept Pharmaceuticals Inc Option Ex 2,825 10.75 30,368
2014-01-16 ICPT Intercept Pharmaceuticals Inc Sale 3,250 267.94 870,805
2013-12-18 ICPT Intercept Pharmaceuticals Inc Sale 260 55.52 14,436
2013-10-16 ICPT Intercept Pharmaceuticals Inc Option Ex 324 .00 0
2013-07-16 ICPT Intercept Pharmaceuticals Inc Option Ex 325 .00 0
2013-06-14 SGEN Seattle Genetics Inc /wa Option Ex 5,000 8.38 41,900
2013-06-14 SGEN Seattle Genetics Inc /wa Sale 5,000 32.75 163,750
2013-05-10 SGEN Seattle Genetics Inc /wa Option Ex 17,500 12.76 223,300
2013-05-10 SGEN Seattle Genetics Inc /wa Sale 17,500 37.17 650,422
2013-04-16 ICPT Intercept Pharmaceuticals Inc Option Ex 324 .00 0
2013-04-09 ICPT Intercept Pharmaceuticals Inc Option Ex 325 .00 0
2013-02-15 MEIP Marshall Edwards Inc Sale 197,225 6.60 1,301,685
2013-02-19 MEIP Marshall Edwards Inc Sale 300,000 6.80 2,040,000
2012-10-16 ICPT Intercept Pharmaceuticals Inc Buy 700,000 15.00 10,500,000
2012-07-24 DRTX Durata Therapeutics, Inc. Buy 784,313 9.00 7,058,817
2012-06-26 GEVA Trimeris Inc Sale 28,827 40.16 1,157,663
2012-06-27 GEVA Trimeris Inc Sale 313,451 39.70 12,444,004
2012-03-19 GEVA Trimeris Inc Sale 342,278 32.55 11,141,148
2011-07-19 TSPT Novacea Inc Sale 82,535 4.45 367,198
2011-07-18 TSPT Novacea Inc Sale 162,527 4.49 729,258
2011-07-13 TSPT Novacea Inc Sale 168,235 5.02 843,866
2011-07-14 TSPT Novacea Inc Sale 41,718 4.85 202,248
2010-10-19 WHRT World Heart Corp Buy 2,341,920 2.13 4,999,999
2010-06-21 SGEN Seattle Genetics Inc /wa Option Ex 50,000 7.37 368,300
2010-01-26 WHRT World Heart Corp Buy 388,350 5.15 2,000,002
2009-08-18 SGEN Seattle Genetics Inc /wa Buy 4,905 11.47 56,260
2009-06-25 SGEN Seattle Genetics Inc /wa Buy 5,500 9.21 50,638
2008-09-22 SGEN Seattle Genetics Inc /wa Sale 18,601 12.79 237,906
2008-09-19 SGEN Seattle Genetics Inc /wa Sale 37,011 12.74 471,520
2008-09-18 SGEN Seattle Genetics Inc /wa Sale 20,839 12.71 264,863
2008-07-29 SGEN Seattle Genetics Inc /wa Sale 95,688 10.85 1,038,214
2008-07-28 SGEN Seattle Genetics Inc /wa Sale 21,232 10.36 219,963
2008-07-25 SGEN Seattle Genetics Inc /wa Sale 148,136 10.81 1,601,350
2008-05-16 SGEN Seattle Genetics Inc /wa Sale 42,059 10.39 436,993
2008-05-15 SGEN Seattle Genetics Inc /wa Sale 98,758 10.14 1,001,406
2008-05-13 SGEN Seattle Genetics Inc /wa Sale 50,896 10.06 512,013
2008-05-14 SGEN Seattle Genetics Inc /wa Sale 121,365 10.10 1,225,786
2007-12-10 SGEN Seattle Genetics Inc /wa Sale 20,960 12.63 264,724
2007-02-09 SGEN Seattle Genetics Inc /wa Sale 2,015,000 8.57 17,268,550

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Akkaraju Srinivas (Director of Versartis, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.